PROCEPT BioRobotics EVP sells 297 shares

EVP and chief legal officer Alaleh Nouri sold a small number of PRCT shares to cover taxes after RSU vesting, retaining over 127,000 shares.

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp (PRCT) executive Alaleh Nouri, EVP, CLO and Corporate Secretary, reported a small sale of common stock primarily for tax purposes. On September 9, 2026, 297 shares were sold at $20.953 per share under the company’s sell-to-cover process tied to RSU vesting. Following this tax-withholding sale, Nouri directly holds 127,737 shares of PROCEPT BioRobotics common stock.

Insider Trade Summary

Net Seller: 297 shares

Net Sell 1 txn

Insider Nouri Alaleh

Role EVP, CLO, CORP. SEC.

Sold 297 shs ($6K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	297	$20.953	$6K

Holdings After Transaction: Common Stock — 127,737 shares (Direct)

Footnotes (1)

1. F1. The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026.

Key Figures

Shares sold: 297 shares Sale price per share: $20.953 per share Shares held after transaction: 127,737 shares +1 more

4 metrics

Shares sold 297 shares Common stock sale reported for September 9, 2026

Sale price per share $20.953 per share Price for the 297 common shares sold on September 9, 2026

Shares held after transaction 127,737 shares Direct holdings of Alaleh Nouri following the reported sale

RSU vesting date September 5, 2026 Date of Restricted Stock Units vesting that triggered tax withholding sale

Key Terms

sell-to-cover process, Restricted Stock Units, tax withholding obligations

3 terms

sell-to-cover process financial

"sold by the reporting person pursuant to the Issuer's sell-to-cover process"

Restricted Stock Units financial

"in connection with the vesting of the Restricted Stock Units on September 5, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"process for tax withholding obligations in connection with the vesting"

FAQ

What did PROCEPT BioRobotics (PRCT) insider Alaleh Nouri report on this Form 4?

Alaleh Nouri reported selling 297 shares of PROCEPT BioRobotics common stock on September 9, 2026, as part of a sell-to-cover tax withholding transaction related to the vesting of Restricted Stock Units.

How many PRCT shares were sold and at what price in this transaction?

Alaleh Nouri sold 297 shares of PROCEPT BioRobotics common stock at a price of $20.953 per share on September 9, 2026, according to the Form 4 filing.

Why were the PRCT shares sold by Alaleh Nouri?

The filing states the shares were sold pursuant to the issuer’s sell-to-cover process to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units on September 5, 2026.

How many PRCT shares does Alaleh Nouri hold after this transaction?

After the September 9, 2026 sale, Alaleh Nouri directly holds 127,737 shares of PROCEPT BioRobotics common stock, as reported in the Form 4 filing.

Was this PRCT insider sale made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the footnote describes the sale as part of the issuer’s sell-to-cover tax process, not a pre-arranged Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:45 PM Accepted by SEC EDGAR 09/10/2026 - 04:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nouri Alaleh

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLO, CORP. SEC.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2026		S(1)		297	D	$20.953	127,737	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)